Navigation Links
Food, Drug, Medical Device Recalls Continue to Climb According to ExpertRECALL Quarterly Index

INDIANAPOLIS, Nov. 3, 2011 /PRNewswire/ -- Food recalls in the third quarter affected nearly six times as many units as the previous three-month period, according to the quarterly ExpertRECALL™ Index, released today. The ExpertRECALL Index also found that pharmaceutical and medical device recalls increased while recalls for children's and infants' products and consumer goods hit surprising five-quarter lows.


Undeclared allergens remained the leading factor in initiating food recalls, as more than 50 percent of all food products were recalled for this reason during the third quarter. Listeria-related recalls were the second-leading cause, accounting for 25 percent of all food recalls listed on the U.S. Food and Drug Administration's website between July and September.

"Based on third-quarter recall activity, product safety remains a hot topic among consumers, manufacturers, retailers and regulators," said Mike Rozembajgier, Vice President of Recalls at Stericycle ExpertRECALL. "Now, as we enter the holiday season, everyone should be reminded of their role in supporting consumer safety to make sure that not only the products we use, but also the gifts we give, are safe for everyone."

"Manufacturers and retailers must pay close attention to consumer safety and be more diligent when communicating with consumers, particularly as shoppers increase their purchases during the holiday season," added Rozembajgier. "And while regulators will need to pay close attention to product safety complaints, particularly about the hottest gifts of the season, consumers need to keep their eyes and ears open for recall announcements about not only the products they buy for themselves, but also about the gifts they are giving."

Burn hazards and structural-collapse risks replaced laceration concerns as the main causes of consumer product recalls during the third quarter as recalls in this category dropped 20 percent from the previous quarter. Children's and infant product recalls decreased for the third straight quarter, also recording a five-quarter low. More than 40 percent of these recalls were initiated by the CPSC out of a concern for the choking risk associated with small parts, the primary cause of recalls in this category.

According to FDA Enforcement reports, 16 percent fewer pharmaceutical units were affected compared to the second quarter of 2011, despite an increase in the number of recall events in the third quarter.

The ExpertRECALL Index also tracks medical device recalls as documented in FDA Enforcement Reports, revealing a modest increase in recalls in the third quarter compared to the average number of recalls in the prior two quarters. Third-quarter recalls involved nearly double the number of units compared to the second quarter.

The 2011 third-quarter ExpertRECALL Index is the only report that aggregates and tracks cumulative recall data from the CPSC and the FDA. Stericycle ExpertRECALL compiles the ExpertRECALL Index from data issued by the U.S. Food and Drug Administration and the Consumer Product Safety Commission. The ExpertRECALL Index report is available online at

About Stericycle ExpertRECALL™

Stericycle ExpertRECALL™ is the industry leader in managing consumer product, pharmaceutical, medical device, juvenile product, and food and beverage recalls. Stericycle ExpertRECALL streamlines the entire product recall process and manages Notification & Response, Processing & Tracking, and Compliance & Reporting for a variety of companies. For more information, visit


SOURCE Stericycle ExpertRECALL
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Poll: 74% Support Banning Sale of Expired Baby Food, Formula and Over-the-Counter Meds
2. International Medical Corps Team in Hardest-Hit Coastal Communities Finds Severe Shortages of Food, Water, Medicines; Acute Need for Mental Health Support
3. Tickets On Sale Now: Bridge to Hope All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Masons Great Meadow
4. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
5. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
6. The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
7. Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001
8. Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland
9. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10. Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL
11. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
Post Your Comments:
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Allergan plc ... an agreement with the New York State ... 2 of the Sherman Act, and other statutes with the ... in February 2014, to cease marketing and selling the now ... of settlement, Allergan admits no liability, has released its counterclaims ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 23rd ... Tri Lite’s personal heating products business. Cozy Products explains what this means ... that fit in well with the Cozy Products business model: to sell personal heaters ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... PA (PRWEB) , ... November 25, 2015 , ... ... treat my cancer, I found that regular bras were incredibly uncomfortable," said an ... developed this specialized bra." , She developed the patent-pending RECOVERY BRA for added ...
Breaking Medicine News(10 mins):